Solid [qlco]    
malignancies [neop]    
patient [podg]    
Wegener Granulomatosis [dsyn]    
Trial [resa]    
Object [inpr]    
Solubility [celc]    
Design [acty]    
To [qlco]    
Arrest [dsyn]    
Wegener Granulomatosis [dsyn]    
Trial [resa]    
placebo-controlled [resa]    
Trial [resa]    
GIVEN [cnce]    
standard therapy [topp]    
Remission Induction [topp]    
Maintenance [acty]    
More [ftcn]    
Solid [qlco]    
malignancies [neop]    
Observation [ftcn]    
Group [idcn]    
Group [idcn]    
TREAT [topp]    
standard therapy [topp]    
Alone [qnco]    
This [euka]    
studies [mnob]    
To [qlco]    
Further [spco]    
Potential [qlco]    
Associate [menp]    
anti-tumor necrosis factor therapy [topp]    
development [phsf]    
malignancies [neop]    
patient [podg]    
Method [inpr]    
One [qnco]    
patient [podg]    
Activate [ftcn]    
WG [dsyn]    
followed [tmco]    
median [spco]    
month [tmco]    
Enrollment [hlca]    
disease characteristic [patf]    
treatment [ftcn]    
Histories [ocdi]    
Specific [qlco]    
Medical History [fndg]    
Item [enty]    
informant [idcn]    
Previous [tmco]    
WG [dsyn]    
treatment [topp]    
Risk factor [qnco]    
malignancies [neop]    
Record [inpr]    
Trial [resa]    
occurrence [ftcn]    
malignancies [neop]    
Adverse event [fndg]    
Record [inpr]    
Result [ftcn]    
Solid [qlco]    
malignancies [neop]    
Observation [ftcn]    
Wegener Granulomatosis [dsyn]    
Trial [resa]    
Occur [acty]    
Group [idcn]    
placebo [topp]    
Group [idcn]    
base [ftcn]    
Comparison [acty]    
Age [orga]    
Sex [orgf]    
Specific [qlco]    
Incidence Rate [qnco]    
1+ [qnco]    
Solid [qlco]    
malignancies [neop]    
Expectancy [idcn]    
Group [idcn]    
Solid [qlco]    
malignancies [neop]    
include [ftcn]    
+2 [qnco]    
Case [ftcn]    
Mucinous Adenocarcinoma [neop]    
Colon [bpoc]    
I- [inch]    
Metastatic [ftcn]    
Cholangiocarcinoma [neop]    
Renal Cell Carcinoma [neop]    
Breast Carcinoma [neop]    
I- [inch]    
Recurrent Liposarcoma [neop]    
*Difference [qnco]    
+2 [qnco]    
treatment [ftcn]    
Group [idcn]    
Sex Distribution [qnco]    
disease severity [qlco]    
Person [orga]    
Family history [fndg]    
Cancer [neop]    
ALCOHOL USE [inbe]    
Group [idcn]    
Old [tmco]    
baseline [bodm]    
less [inpr]    
Likely [qlco]    
newly [idcn]    
diagnose [fndg]    
WG [dsyn]    
Time [tmco]    
RANDOM [resa]    
patient [podg]    
solid tumor [neop]    
Old [tmco]    
patient [podg]    
Not [ftcn]    
TREAT [topp]    
patient [podg]    
solid tumor [neop]    
TREAT [topp]    
Trial [resa]    
*Difference [qnco]    
Group [idcn]    
Amount [qnco]    
Receive [qlco]    
Trial [resa]    
Percentage [qnco]    
Receive [qlco]    
Enrollment [hlca]    
*Difference [qnco]    
Mean [qnco]    
Duration [tmco]    
Daily [tmco]    
Therapies [ftcn]    
Maximum [qnco]    
Daily [tmco]    
Dosage [qnco]    
Enrollment [hlca]    
Conclusion [idcn]    
Data [idcn]    
Wegener Granulomatosis [dsyn]    
Trial [resa]    
First [qnco]    
Report [inpr]    
experience [menp]    
Combination [qlco]    
use [ftcn]    
treatment [ftcn]    
WG [dsyn]    
Combination [qlco]    
inhibited [menp]    
heighten [qlco]    
Risk [qlco]    
Cancer [neop]    
Observation [ftcn]    
Alone [qnco]    
